Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Expands By 127.4%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFFGet Free Report) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 48,900 shares, an increase of 127.4% from the February 13th total of 21,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Laboratorios Farmaceuticos Rovi stock opened at C$65.86 on Friday. The firm has a 50-day moving average of C$65.86 and a 200-day moving average of C$76.94. Laboratorios Farmaceuticos Rovi has a 1-year low of C$65.86 and a 1-year high of C$65.86.

About Laboratorios Farmaceuticos Rovi

(Get Free Report)

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.

Featured Stories

Receive News & Ratings for Laboratorios Farmaceuticos Rovi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and related companies with MarketBeat.com's FREE daily email newsletter.